About US
Contact us
-
Crestor drives AstraZeneca financialsAstraZeneca cholesterol drug Crestor drove the company's third-quarter financials forward as generic competition significantly affected other medications. Although revenues fell 2% to approximately $2011/11/1
-
SFDA Commissioner Shao Mingli meets Belgian Vice Prime Minister and Minister of Foreign Affairs and Institutional ReformOn October 24, 2011, the Belgian delegation led by Mr. Steven Vanackere, Vice Prime Minister and Minister of Foreign Affairs and Institutional Reform of Belgium, visited the State Food and Drug Admini2011/10/28
-
EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13Pfizer Inc. (NYSE: PFE) announced today that the European Commission has approved the Company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, a2011/10/28
-
Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines"Scientists are warning officials negotiating a global treaty on mercury that banning the deadly chemical completely would be dangerous for public health because of the chemical's use invaccines," the2011/10/25
-
Lilly earnings fall despite sales increaseEli Lilly has reported a decline in it third quarter earnings despite a 9% sales increase attributed to its Cymbalta and Alimta medications. Earnings fell 5%, with net income falling to $1.24bn, as h2011/10/25
-
SFDA Commissioner Shao Mingli meets U.S. Department of Commerce Biotechnology and Life Sciences Trade Mission to ChinaOn October 14, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA), met with the U.S. Department of Commerce Biotechnology and Life Sciences Trade Mission to China led by2011/10/21
-
SFDA Deputy Commissioner Bian Zhenjia attends 2011 Sino-U.S. Pharmaceutical Industry SummitThe 2011 Sino-U.S. Pharmaceutical Industry Summit, jointly organized by the China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA) and the Pharmaceutical Research and Manufac2011/10/21
-
Roche to acquire AnadysRoche has signed a definitive merger agreement to acquire Anadys Pharmaceuticals, a manufacturer of antiviral drug compunds, for a total cash consideration of approximately $230m. As per the merger a2011/10/20
-
SFDA promulgates Measures for Drug Supervision and Management in Medical Institutions (interim)In order to strengthen the drug quality supervision in medical institutions, further standardize the use of drugs of medical institutions, the State Food and Drug Administration (SFDA) recently promul2011/10/19
-
Roquette Pharma Introduces New Natural Inert Polymer and Ready to Use Coating SystemRoquette Pharma's new natural inert polymer and ready to use coating system for fast aqueous film coating saves time by up to 50% or more. The key benefits are: Natural origin Superior organolept2011/10/19